Members of Congress are pushing to stop the Food and Drug Administration from approving genetically engineered salmon, saying not enough is known about a fish they say could harm fishery businesses in coastal states.
It appeared last year that the FDA might approve the engineered salmon quickly. But the congressional pushback and a lack of action by the FDA could mean the fish won’t be on the nation’s dinner tables any time soon.
The fish, which grows twice as fast as the conventional variety, is engineered by AquaBounty, a Massachusetts-based company, but not yet allowed on the market. The company’s application has been pending for more than 15 years. If the agency approves it, it would be the first time the government allows such modified animals to be marketed for people to eat.
Congressional opposition to the engineered fish is led by members of the Alaska delegation. They see the modified salmon as a threat to the state’s wild salmon industry.